Potential Alzheimer’s Drug Not Enough to Excite Biogen Stock Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biogen opened higher by around 10% on news of its Alzheimer's drug. By the end of day, BIIB stock gave up a bulk of its gains. What gives? The post Potential Alzheimer’s Drug Not Enough to Excite Biogen Stock Investors appeared first on InvestorPlace . More From InvestorPlace Why Everyone Is Investing in 5G All WRONG America’s #1 Stock Picker Reveals His Next 1,000% Winner Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company Radical New Battery Could Dismantle Oil Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.